Search peptides, terms, sources/

Research areas

The questions peptide research has looked at. An area records what was studied, not a proven effect.

  • Cognitive Research

    "Cognitive Research" covers peptides studied for effects on brain function, including memory, neuroprotection, neurotrophic signalling and social cognition such as trust or emotional processing. Evidence in this category ranges from rodent gene-expression and neurotrophic-factor studies through to small human clinical trials, including stroke-recovery research and social-cognition studies using functional neuroimaging. As with every Research Area, classification here reflects a genuine line of published cognitive-science enquiry, not a validated cognitive or therapeutic effect.

    4 peptides
  • Dermatological & Pigmentation Research

    "Dermatological & Pigmentation Research" groups peptides studied for effects on skin pigmentation, melanogenesis and related dermatological outcomes, including both the mechanisms driving pigmentation change and the safety literature examining pigmented-lesion changes associated with that mechanism. Evidence in this category includes early-phase human dosing studies alongside case reports and case-series safety literature published in the dermatology field. This category currently reflects a narrow evidence base and is expected to broaden as further peptides researched in this area are added to the catalogue.

    2 peptides
  • Growth Hormone Research

    "Growth Hormone Research" covers peptides studied for their action on the growth-hormone-releasing hormone (GHRH) receptor or the ghrelin/GH-secretagogue receptor pathway, and their downstream effect on pituitary growth hormone release and circulating IGF-1. Research in this area includes human dose-escalation pharmacokinetic studies, diagnostic-use trials in paediatric growth-hormone deficiency, and body-composition trials in specific clinical populations. Peptides in this category differ considerably in the strength, age and regulatory history of their supporting evidence; inclusion reflects a shared mechanism of research interest, not equivalent evidence quality across peptides.

    8 peptides
  • Healing & Recovery

    "Healing & Recovery" organises research into tissue repair processes, including tendon, ligament, muscle, gastrointestinal and skin healing, drawn predominantly from animal and preclinical models with a smaller body of human observational and case-series evidence. The peptides classified here have been investigated for mechanisms such as angiogenesis, cell migration and collagen or extracellular-matrix remodelling, rather than for a single confirmed clinical indication. Evidence density and study quality vary considerably between peptides within this category; a peptide's presence here indicates a documented line of healing-related research, not a demonstrated recovery benefit.

    4 peptides
  • Immune & Infectious Disease Research

    "Immune & Infectious Disease Research" groups peptides studied for immunomodulatory effects and outcomes in infectious or critical-illness contexts, including sepsis, chronic viral hepatitis and immune-marker changes during recovery from acute illness. Evidence in this category spans mechanistic dendritic-cell and Toll-like-receptor research through to systematic reviews and meta-analyses of randomised controlled trials, with reported outcomes that are mixed rather than uniformly positive, including a primary meta-analysis whose result was no longer statistically significant once restricted to higher-quality trial subsets. Inclusion in this category reflects a substantial published immunology and infectious-disease research literature, not a confirmed treatment effect for any condition.

    2 peptides
  • Longevity & Ageing Research

    "Longevity & Ageing Research" groups peptides studied in relation to biological ageing processes, including telomere biology, age-related skin changes and functional decline in aged animal models, together with a small number of human trials conducted specifically in older-adult populations. The underlying evidence for this category is disproportionately preclinical or drawn from small, dated human studies, and independent replication is limited across the peptides classified here. A peptide's presence in this category reflects that ageing-related research questions have been asked about it, not that any anti-ageing effect has been established.

    4 peptides
  • Metabolic Research

    "Metabolic Research" groups peptides investigated for effects on glucose regulation, insulin sensitivity, lipid metabolism, visceral fat and related body-composition markers. It is distinct from the broader Weight Management category in that the underlying research question is metabolic function rather than body-weight outcome specifically, though the two frequently overlap in practice. Evidence spans in-vitro and animal-preclinical mechanistic work through to human randomised controlled trials, and includes at least one case where a controlled human trial testing a metabolic endpoint reported no significant effect. Classification in this area denotes a studied metabolic research question, not a confirmed metabolic benefit.

    11 peptides
  • Mood & Behavioural Research

    "Mood & Behavioural Research" covers peptides studied for effects on mood, anxiety and behavioural regulation, distinct from the broader Cognitive Research category, which concerns memory, neuroprotection and related brain-function outcomes rather than mood or anxiety specifically. Evidence in this category includes a human active-comparator clinical trial in generalised anxiety disorder and neurasthenia, alongside animal gene-expression research into GABAergic neurotransmission. As with the site's other Research Areas, classification here indicates a documented behavioural-science research question, not a demonstrated anxiolytic or mood benefit.

    1 peptide
  • Sexual & Reproductive Health Research

    "Sexual & Reproductive Health Research" covers peptides studied in relation to sexual desire, arousal, reproductive endocrinology and licensed obstetric uses such as labour induction. Evidence in this category includes randomised, placebo-controlled human trials in hypoactive sexual desire disorder using functional neuroimaging and clinical desire/distress endpoints, alongside fertility research into oocyte maturation triggering during IVF. Because this category deals with reproductive and sexual physiology specifically, inclusion here is a statement about the research question studied, never about efficacy, safety or suitability for any individual's circumstances.

    3 peptides
  • Weight Management

    "Weight Management" groups peptides that have been studied for effects on appetite, food intake, energy metabolism or body weight, most commonly incretin-mimetic and amylin-pathway compounds investigated in randomised, placebo-controlled human trials. Published research in this area spans mechanisms such as GLP-1 and GIP receptor agonism, amylin-receptor activation and lipolytic signalling, with study designs ranging from receptor-binding assays through to large multi-centre Phase 3 trials. Inclusion here reflects that a peptide's effect on weight-related endpoints has been formally investigated, not that any outcome, positive, negative or mixed, has been established as reliable.

    10 peptides
  • Bone Health Research

    "Bone Health Research" groups peptides studied for effects on bone formation, bone density and fracture risk, most commonly parathyroid-hormone-pathway peptides investigated in osteoporosis. Evidence in this category includes large randomised phase 3 fracture trials, active-comparator trials and long-term surveillance studies, alongside animal carcinogenicity findings that shape licensed-use warnings. Inclusion here reflects a documented line of bone-related research, not an effect for any individual.

    2 peptides
  • Mitochondrial Research

    "Mitochondrial Research" groups peptides studied for effects on mitochondrial function, including rare inherited mitochondrial diseases. Evidence in this category ranges from cell and animal work to small human trials in ultra-rare conditions and one large phase 3 trial that did not meet its endpoints. Inclusion reflects a documented line of mitochondrial research, not a demonstrated benefit.

    1 peptide

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.